{"database": "openregs", "table": "documents", "rows": [["FDA-2017-N-6381-0013", "FDA", "FDA-2017-N-6381", "FDA tab B - Postmarket Safety Reports for NAD - RIA (OMB redline compare 3-18-20 to 6-11-20) RE Memorandum to DMS - Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements (Final Rule)", "Supporting & Related Material", "Background Material", "2020-10-01T04:00:00Z", 2020, 10, null, null, "2020-10-01T18:19:41Z", null, 0, 0, "09000064848af132"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2017-N-6381-0013"], "units": {}, "query_ms": 77.42348499596119, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}